dafabet online betting website

According to the National Basic Medical Insurance in 2024、Work arrangements for the adjustment of the work injury insurance and maternity insurance drug catalog (hereinafter referred to as the national medical insurance drug catalog)，With the support of relevant departments，The National Medical Insurance Administration recently conducted a preliminary formal review of applied drugs，And the drugs and information that passed the review were publicized。The relevant work situation is explained as follows。

　　dafabet online betting website

The formal review is to review whether the applied drug meets the application conditions for the adjustment of the national medical insurance drug catalog that year and the completeness of the drug information。According to work arrangement，Formal review is mainly divided into preliminary review、Preliminary review results announced、Review、Four steps for review result announcement。The content of this announcement is this year’s preliminary review results。A drug passed preliminary formal review，Only means that it meets the declaration conditions，Qualified to participate in directory adjustment，It does not mean that it has entered the national medical insurance drug catalog。

In accordance with the "Interim Measures for the Management of Drug Use under Basic Medical Insurance"，Adjustment of the National Medical Insurance Drug Catalog and Implementation of Enterprise Application System。The National Medical Insurance Administration adjusts the work plan according to the national medical insurance drug catalog of the year，Determine application conditions and requirements according to procedures，Voluntary declaration by each reporting entity。Conduct formal review of drug application materials，On the one hand, it can ensure that the applied drugs meet the application conditions，On the other hand, the integrity of the application materials、Review in a standardized manner，And verify the authenticity of some information with relevant parties according to work needs，Conducive to ensuring the accuracy and completeness of the information provided to experts in the subsequent stages。At the same time，To ensure that directory adjustments are open and transparent，We will publish the drugs and some information that have passed the preliminary review results，It is also a way to actively accept supervision，We welcome valuable opinions and suggestions from all walks of life。

　　二、Does passing the preliminary formal review mean that it has been included in the National Medical Insurance Drug Catalog？

In accordance with the "Interim Measures for the Administration of Drug Use in Basic Medical Insurance" and the "2024 National Basic Medical Insurance、Work Plan for Adjusting the Drug Catalog dafabet casino mobile appof Work-related Injury Insurance and Maternity Insurance” (hereinafter referred to as the “Work Plan”)，Adjustment of the medical insurance drug catalog is divided into enterprise declarations、Form review、Expert review、Negotiation, bidding, etc.，Formal review is just one of them。A drug passed preliminary formal review，Does not mean it has entered the medical insurance directory，Only means that the drug meets the corresponding application conditions after review，Preliminarily qualified to participate in the next step of the review。

　　三、What are the changes in the enterprise application and preliminary formal review of the adjustment of the National Medical Insurance Drug Catalog in 2024 compared with last year？

　July 1, 2024 9:00 to July 14, 17:00，Received a total of 626 corporate declaration information，Involving drugs (generic name，The same below) 574。Audited，440 drugs passed preliminary formal review。Compared to 2023，The number of declared drugs has increased。

　　four、How to treat some drugs that are currently relatively expensive in the market and are obviously beyond the scope of basic medical insurance coverage and have passed the preliminary formal review？

Since its establishment，The National Medical Insurance Administration resolutely implements the Party Central Committee、Decision-making and deployment of the State Council，Always firmly grasp the functional positioning of basic medical insurance to “protect the basics”，Insist on doing your best、Act within your capabilities，Determine dafabet casino mobile appthe scope of protection realistically;Always adhere to stability and sustainability，Use the medical insurance fund and the affordability of the insured people as the basis for catalog adjustment，Significantly reduce the price of exclusive drugs through access negotiations and other methods;Always focus on the balance between the basic medical needs of the people and the progress of clinical technology，Improve accessibility，Maintain fairness。Some relatively expensive drugs that are obviously beyond the scope of basic medical insurance have passed the preliminary formal review，It only means that the drug meets the application conditions，Acquired the qualification to enter the next stage。Can these types of drugs eventually enter the national medical insurance drug catalog?，Still needs to go through strict review process，Then exclusive drugs need to be negotiated、Non-exclusive drugs require bidding，Only after successful negotiation or bidding can it be finally included in the catalog。

　　5. How will the work be carried out after this announcement?

Next step，We will base on the feedback received during the public announcement period，Further verify relevant information，Determine the list of drugs that have finally passed the formal review，And announce it to the public。Subsequently，We will follow the requirements of the "Work Plan"，Promote expert review、Negotiation, bidding and other follow-up work。

Source: National Medical Security Administration